ducovest

ENSG:NSD-The Ensign Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 144.55

Change

0.00 (0.00)%

Market Cap

USD 7.86B

Volume

0.26M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Company Website : https://ensigngroup.net

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
OPCH Option Care Health Inc

N/A

 USD 5.14B
AMED Amedisys Inc

N/A

 USD 3.13B
PIII P3 Health Partners Inc

N/A

 USD 2.88B
SGRY Surgery Partners Inc

N/A

 USD 2.84B
ACHC Acadia Healthcare Company Inc

N/A

 USD 2.20B
LFST Lifestance Health Group Inc

N/A

 USD 2.13B
ADUS Addus HomeCare Corporation

N/A

 USD 2.04B
ASTH Astrana Health Inc

N/A

 USD 1.25B
AVAH Aveanna Healthcare Holdings In..

N/A

 USD 1.07B
HCSG Healthcare Services Group Inc

N/A

 USD 1.06B

ETFs Containing ENSG

SCDV ETF Series Solutions 6.30 % 0.00 %

N/A

 N/A
RISN Inspire Tactical Balanced.. 3.54 % 0.00 %

N/A

 USD 0.08B
XHS SPDR® S&P Health Care Se.. 2.21 % 0.35 %

N/A

 USD 0.09B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

 N/A
ETLZ:XETRA L&G Russell 2000 US Small.. 0.59 % 0.00 %

N/A

 USD 0.09B
DFAS Dimensional U.S. Small Ca.. 0.25 % 0.00 %

N/A

 USD 9.63B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

N/A

 N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

N/A

 USD 0.44B
OLD 0.00 % 0.50 %

N/A

 N/A
BOUT Innovator ETFs Trust - In.. 0.00 % 0.80 %

N/A

 USD 0.01B
KSCD 0.00 % 0.00 %

N/A

 N/A
SLY 0.00 % 0.15 %

N/A

 N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

N/A

 N/A
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

N/A

 N/A
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

N/A

 N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

 USD 0.19B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

 USD 0.19B
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

 N/A
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

 N/A
SMLE 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.80% 63% D 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.80% 63% D 79% B-
Trailing 12 Months  
Capital Gain 20.30% 71% C- 78% C+
Dividend Return 0.20% 100% F 3% F
Total Return 20.50% 71% C- 77% C+
Trailing 5 Years  
Capital Gain 234.30% 100% F 92% A
Dividend Return 2.60% 50% F 5% F
Total Return 236.89% 100% F 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 19.39% 79% B- 77% C+
Dividend Return 19.66% 79% B- 77% C+
Total Return 0.27% 50% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 25.05% 82% B 67% D+
Risk Adjusted Return 78.47% 100% F 92% A
Market Capitalization 7.86B 100% F 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.